companydata.dkcompanydata.dk

Epista Life Science A/S: Financial statements 2025

CVR: 32141064

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Epista Life Science A/S (CVR 32141064) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. That is an increase of 28.5% compared with the year before. Equity in the 2025 report amounted to DKK 42,811,282. The solvency ratio was 30.5%. The company had 105 employees in the financial year.

Gross Profit
DKK 104,009,512
Profit/Loss
DKK -40,340,814
Equity
DKK 42,811,282
Total Assets
DKK 140,293,737
Employees
105

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-104M-40.3M42.8M105
2024-80.9M-12.5M29.3M69
2023-79.7M10.5M39M48
2022-46.8M4.7M28.8M51
2021-48.2M9.1M14.7M48

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Epista Life Science A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Maximilian Verfürden Weimann joins the board of Epista Life Science A/SAug 18, 2025

As of August 18, 2025, Maximilian Verfürden Weimann has joined the board of directors of Epista Life Science A/S.

Line Hyldgaard Hjorth-Christensen leaves the board of Epista Life Science A/SAug 18, 2025

As of August 18, 2025, Line Hyldgaard Hjorth-Christensen has left the board of directors of Epista Life Science A/S.

Klavs Esbjerg joins Epista Life Science A/S as adm. dir.Aug 18, 2025

As of August 18, 2025, Klavs Esbjerg is registered as adm. dir. of Epista Life Science A/S.

Klavs Esbjerg steps down as director of Epista Life Science A/SAug 17, 2025

As of August 17, 2025, Klavs Esbjerg has stepped down as director of Epista Life Science A/S.

Epista Life Science A/S: The 2024 annual report is outJul 1, 2025

Epista Life Science A/S has published its annual report for 2024. Gross profit came to DKK 80,942,136, and the net result was DKK -12,458,230.

About Epista Life Science A/S

Epista Life Science A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named EPISTA IT A/S and EPISTA IT ApS. The management consists of Per Erik Mikael Johansson. The board consists of Simon Carl Vilhelm Larsson (chair), Katarína Larsen and Klavs Esbjerg. The company is owned by Enhance BidCo ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. Equity in the 2025 report amounted to DKK 42,811,282.

Source: annual report 2025, Danish Business Authority